NCT02619136 (MINT) is a NA clinical trial of Transfusion in Myocardial Infarction, sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

Who is sponsoring NCT02619136?

NCT02619136 is sponsored by Centre hospitalier de l'Université de Montréal (CHUM).

What drugs are being tested in NCT02619136?

Interventions in NCT02619136: Transfusion.

What condition does NCT02619136 study?

NCT02619136 studies Myocardial Infarction.

Is NCT02619136 still recruiting?

NCT02619136 is currently status unknown. Last updated 27 July 2023.

Last reviewed 2023-07-27 · How we verify

NCT02619136: MINT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Myocardial Ischemia and Transfusion

Status unknown NA Last updated 27 July 2023

What this trial tests

NA trial testing Transfusion in Myocardial Infarction in 3,501 participants. Status unknown.

Timeline

30 June 2016

Primary endpoint
30 November 2023

30 November 2023

Quick facts

Lead sponsor	Centre hospitalier de l'Université de Montréal (CHUM)
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	3,501
Start date	30 June 2016
Primary completion	30 November 2023
Estimated completion	30 November 2023
Sites	4 locations across Canada

Drugs / interventions tested

Transfusion — full drug profile →

Conditions studied

Myocardial Infarction — all drugs for Myocardial Infarction →

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Who can join

18 and older, any sex, with Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

MINT: A pilot, multi-centre, open-label randomized controlled trial of two commonly used transfusion strategies in patients with myocardial infarction.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.
Carson JL, Stanworth SJ, Roubinian N, Fergusson DA, et al · · 2016 · cited 232× · PMID 27731885 · DOI 10.1002/14651858.cd002042.pub4
Transfusion thresholds for guiding red blood cell transfusion.
Carson JL, Stanworth SJ, Dennis JA, Trivella M, et al · · 2021 · cited 165× · PMID 34932836 · DOI 10.1002/14651858.cd002042.pub5

Verify or expand the search:

Other trials of Transfusion

Trials testing the same drug.

NCT06403163 — Transfusion Surveillance in Anaesthesia · recruiting
NCT03643042 — Impact of 2 Transfusion Strategies on Quality of Life of Multitransfused Patients With Low-risk Myelodysplastic Syndrome · NA · terminated
NCT05452538 — AutoTransfusion Versus TRAnsfusion in Cancer Surgery · completed
NCT04194047 — Effects of Red Blood Cells Transfusion on Renal Blood Flow · completed
NCT04164849 — Extracorporeal Photopheresis of Patients With Crohn's Disease Using 5-aminolevulinic Acid · Phase 1, PHASE2 · completed

Other recruiting trials for Myocardial Infarction

Currently open trials in the same condition.

NCT07257198 — Aspirin-free Strategy With Ticagrelor in Patients With a Myocardial Infarction Treated Medically Alone · Phase 3 · recruiting
NCT07402642 — Effect of Early Educational Intervention on Cardiovascular Risk Factors After Acute Coronary Syndrome · NA · recruiting
NCT07301034 — A Research Study to Look at the Effect of Ziltivekimab on Plaque in the Blood Vessels of the Heart, Compared to Placebo, · Phase 3 · recruiting
NCT07142265 — Evaluation of 1-Year Clinical Outcomes With Early Inclisiran Initiation in Post-MI Patients · recruiting
NCT07138911 — Effect of Home-based Exercise Plan Mediated by Use of Digital Health App on Kinesiophobia and Functional Capacity · NA · recruiting

Other Centre hospitalier de l'Université de Montréal (CHUM) trials

Trials by the same sponsor.

NCT06735638 — Outside the Cage (OTC) Robotic Esophagectomy · Phase 1 · not yet recruiting
NCT07533253 — Rescue Distal Thrombectomy in Treatment for Persistent Distal Occlusions · NA · not yet recruiting
NCT05225272 — Effectiveness of an Enhanced Recovery After Surgery Protocol in Patients Undergoing On-pump Cardiac Surgery · not yet recruiting
NCT07497061 — Comparison of Two Surgical Techniques for the Treatment of Trigger Fingers: Longitudinal Opening Versus Complete A1 Pull · NA · not yet recruiting
NCT07196410 — KAN-004 for Immune-Related Diarrhea or Colitis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02619136 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre hospitalier de l'Université de Montréal (CHUM)
Last refreshed: 27 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02619136.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing